PubMed Health⌕ Search

Biomedical subjects

N Allen

Publications and source records attributed to N Allen.

At least 55 records · Page 3Linked to original sources

A causal analysis of early drug involvement in three inner-city neighborhood settings.

Building upon previous studies stressing the importance of contextual effects in psychosocial behavior, we test a model of drug involvement among inner-city youths living in neighborhoods varying in the perceived degree of toughness/drug use. The drug involvement of the youths is hypothesized to result from the availability of drugs, image of drug-using/gang-involved persons, friends' drug use, and participation in street culture activities. In each of the toughness/drug use settings, image of drug-using/gang-involved persons related positively to friends' use of alcohol and marijuana, friends' use of alcohol and marijuana related positively to participation in street culture spare-time activities and drug involvement, and participation in street culture pursuits related positively to drug involvement. Neighborhood-setting-specific relationships are also observed. The complexity of the model, as reflected in the number of path coefficients, and the ability of the variables in the model to predict the youths' drug involvement increase as we proceed from low toughness/drug use (R2 = .28) to medium toughness/drug use (R2 = .30) to high toughness/drug use (R2 = .38) neighborhoods. The importance of examining youths' environmental experiences in understanding their drug involvement, especially their relationship to neighborhood drug use subcultures, is emphasized.

Adolescent↗

Effect of heparin modification on its circular dichroism spectrum.

The effect of modification of the carboxyl groups of high affinity heparin was investigated. The binding affinity toward antithrombin III decreases in the following order: Heparin greater than heparin methyl ester greater than heparinylglycine greater than heparinylglycine methyl ester. This result agrees qualitatively with the previous studies using unfractionated heparin. Esterification of the carboxyl groups (i.e., HME) does not affect the CD profile of heparin at 210 nm but introduction of a bulkier glycine methyl ester (i.e., HGME) leads to formation of a very intense band at 235 nm. Based on reported CD analyses of uronic acid derivatives and our model building studies, it is concluded that the large difference in CD spectra of HGME as compared to unmodified heparin and HME is due to a change in ring conformation of the uronic acid moiety (i.e., 4C1 to 1C4 or vice versa).

Carbohydrate Conformation↗

Myasthenia gravis in monozygotic twins. Clinical follow-up nine years after thymectomy.

Genetically proved monozygotic female twins in whom myasthenia gravis developed in their 20s initially had their disease well controlled with anticholinesterase medication. Because of increasing resistance to medication, twin 1 had her thymus removed, after which the symptoms decreased. Predicated on the improvement in her sister and the need for increasing medication to allay symptoms, and after proof of monozygosity, twin 2 also underwent thymectomy, with subsequent symptomatic improvement. The twins were followed up nine and six years after thymectomy, respectively. Monozygotic twins with myasthenia gravis are generally young women, with onset of disease in one occurring within one to three years of the other. Reports of only one affected twin may be misleading because of inadequate documentation of monozygosity, absence of long-term observation, or both. Serial investigations of the "uninvolved" twin in a monozygous pair and proof of monozygosity should be obtained to aid in early diagnosis and treatment of this illness, as well as to study the pathogenesis of myasthenia gravis prior to symptom onset.

Adult↗

Refolding properties of antithrombin III. Mechanism of binding to heparin.

The presence of two unfolding domains in antithrombin III during its denaturation in guanidinium chloride has previously been reported (Villanueva, G. B., and Allen, N. (1983) J. Biol. Chem. 258, 11010-11013). In the present work, we report the results of refolding studies on antithrombin III. Circular dichroism and intrinsic fluorescence studies have demonstrated that the first unfolding domain of low stability (midpoint at 0.7 M guanidinium chloride) is irreversible upon renaturation, whereas the second unfolding domain (midpoint at 2.3 M guanidinium chloride) is reversible. The intermediate form of antithrombin III, termed AT-IIIR, which has lost the structural features of the first domain was investigated. Clotting assays and electrophoretic analyses showed that AT-IIIR had lost 60% of heparin cofactor activity but was still capable of forming sodium dodecyl sulfate-stable complexes with thrombin. Although certain regions of this molecule do not refold to the conformation of native antithrombin III, the tryptophan residues refold to a conformation identical with the native state. This was demonstrated by fluorescence quenching, solvent perturbation, and chemical modification studies. However, the tryptophan-ascribed fluorescence enhancement and absorption difference spectrum which occur when heparin binds to antithrombin III are reduced by 70%. On the basis of these data, the binding of heparin to antithrombin III is interpreted in terms of a two-step mechanism. The primary binding occurs in the region without tryptophan and is followed by a secondary conformational rearrangement which affects the tryptophan environment. The mechanism of the binding of heparin and antithrombin III has been previously studied by kinetic methods, and the data also support a two-step mechanism. The agreement of these two studies employing entirely different approaches to the same problem lends support to the validity of this postulated mechanism.

Antithrombin III↗

Demonstration of a two-domain structure of antithrombin III during its denaturation in guanidinium chloride.

The denaturation of human antithrombin III in urea and guanidinium chloride (GdmCl) was investigated by intrinsic fluorescence, circular dichroism, and absorption difference spectroscopy. Results suggest the existence of two structural domains as evidenced by the occurrence of two structural transitions, one at 0.7 M GdmCl and the other at 2.3 M GdmCl. This multistate unfolding transition has been confirmed under various protein concentrations and incubation times using different antithrombin III preparations, including a preparation that had been heated at 60 degrees C in the presence of 0.5 M citrate. The persistence of the multistate transition under these conditions rules out the possibilities that it could be due to the presence of different antithrombin populations in a mixture or the presence of a prosthetic group in the molecule. The first unfolding domain (0.7 M GdmCl) is stabilized by heparin and citrate. These protections suggest that the first unfolding domain of low stability may have functional relevance and important implications with respect to antithrombin III-heparin and antithrombin III-protease interaction.

Antithrombin III↗

Lysosomal isozyme patterns in ethylnitrosourea-induced brain tumors.

Isozyme patterns for five acid hydrolases, acid phosphatase (AP), aryl-sulfate (AS), beta-glucuronidase (beta-Glu), N-acetylglucosaminidase (NAG) and beta-galactosidase (beta-Gal), were studied in isolated lysosomes from ethylnitrosourea (ENU)-induced gliomas and compared with normal and newborn rat brains. With polyacrylamide gel electrophoresis (PAGE), AP was separated into three bands, acidic (A), intermediate (B) and basic (C). In tumors and newborn brains there was a decrease in A and C but a significant increase in B. For NAG the acidic form was elevated by 9-19% in tumors, while newborn brains showed a 19% decrease. Even though the band intensities of beta-Glu in tumors and newborn brains were increased, the relative distribution remained similar to normal brain. With isoelectric focusing, five hydrolases were separated into four to five distinct forms. In ENU-induced gliomas the intensities of all peaks were considerably increased, but in most cases the number of isozymes remained the same. In tumors the isoelectric points were shifted towards the acidic side and smaller peaks in the basic regions merged into more acidic peaks. This effect was especially evident for AP and Gal. In the cases of AS, beta-Glu and NAG, consistently more activity was associated with acidic peaks than with the basic ones. Our data indicates that there is a significant increase in acidic forms of some of the lysosomal hydrolases studied in ENU-induced brain tumors.

Acetylglucosaminidase↗

Further observations on the nature of prosopagnosia.

Two new cases of prosopagnosia are described and compared with pertinent clinical material from the English language literature. The interpretation of this disorder most compatible with the clinical data appears to us to be that there is an underspecification of visuoperceptive information preventing both the formation of significant face images and the retrieval of well-known face memoranda existing within a relatively intact visual remote memory store. Failure of formation of immediate memoranda of similarly complex visual images is also commonly observed but does not seem to be a requirement for the symptom of prosopagnosia. Conceptualizing this abnormality as simply a material specific visual agnosia of images beyond the classifier level would still appear to be acceptable if less informative.

Aged↗

Determination of Cu, Mn, Fe, and Ca in six regions of normal human brain, by atomic absorption spectroscopy.

A method is reported for measuring copper, manganese, iron, and calcium in brain tissue. We solubilized 100-mg samples of brain tissue with Soluene-350 and diluted the mixtures with methyl isobutyl ketone. Copper and manganese concentrations were measured by using a carbon rod atomizer, iron and calcium concentrations by using an air/acetylene and nitrous oxide/acetylene flame, respectively. The basal ganglia (caudate, putamen, globus pallidus, and substantia nigra) contained high concentrations of iron (10 to 19 mumol/g dry wt) as compared to concentrations found in the cortex (4 mumol/g) or the hippocampus (2.8 mumol/g). Copper exhibited a similar distribution pattern among the regions studied; 526 to 1140 mumol/g (dry wt) in the basal ganglia vs 496 mumol/g in the cortex and 426 mumol/g in the hippocampus. Manganese and calcium were uniformly distributed in the regions examined.

Brain Chemistry↗

CSF beta-glucuronidase assay in the diagnosis of neoplastic meningitis.

The clinical value of CSF beta-glucuronidase assay in the differential diagnosis of chronic meningitis had been investigated over the past 20 years. Significant (P < .001), often marked, elevation of the enzyme level was found in the first sample submitted in 29 of 30 cases of neoplastic meningitis, irrespective of treatment (mean, 324 units), and in 12 of 14 untreated cases with meningeal lymphoma (mean, 174 units). On the other hand, untreated patients with chronic meningitis of other etiologies had significantly lower of other etiologies had significantly lower levels of enzyme elevation, eg, leukemic meningitis (mean, 46 units), fungal meningitis (mean, 41 units), and tuberculous meningitis (mean, 79 units). In the few cases of chronic meningitis studied during appropriate therapy, a tendency toward a decrease in enzyme activity was noted, thus offering further diagnostic support. In our opinion, the finding of a marked elevation of beta-glucuronidase activity in a patient with chronic meningitis is presumptive evidence of neoplastic etiology.

Diagnosis, Differential↗

Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.

Deamino-8-D-argenine vasopressin (DDAVP) was given by intravenous infusion to normal subjects, haemophiliacs and patients with von Willebrand's disease (vWd) and the factor VIII and plasminogen activator response was studied. In normal subjects and most patients with mild haemophilia and mild (intermediate) von Willebrand's disease there was an increase in plasminogen activator and all factor VIII related activities. In patients with mild vWd the prolonged bleeding time was shortened by DDAVP despite only a modest rise in factor VIII related Ristocetin cofactor activity (VIIIR:RiCoF). Sub-groups of patients have been characterized in whom atypical responses was observed. In two brothers with clinically severe haemophilia, but with 5--6 u/dl procoagulant factor VIII (VIIIC), there was an increase in VIIIC but no rise of the corresponding antigen, suggesting increased release of an antigenically abnormal poorly functioning molecule. A patient with intermediate vWd was studied in whom neither DDAVP, adrenaline infusion, nor venous occlusion resulted in an increase in either plasminogen activator or factor VIII related antigen (VIIRAg), although there was a significant increase in VIIIC. In a further patient with severe vWd, DDAVP failed to elicit any plasminogen activator or VIII response. The results obtained from these two patients suggested that in some individuals the presumed endothelial cell abnormality in vWd may be more extensive than a defect in VIIIRAg synthesis. Sub-groups of patients have been identified for whom treatment with factor VIII concentrates would be more appropriate than DDAVP prior to minor surgery.

Adolescent↗

An improved rat brain-tumor model.

The widely used intracerebral tumor implantation method by freehand injection into parietal or hippocampal areas of the rat brain has proven inadequate for reliable experimental therapeutic studies. Problems include poor intracerebral growth yields and significant rates of spread to extracranial tissues, lungs, and spinal cord. Major variables have been examined experimentally on a model using nitrosourea-induced nervous system tumor cell lines in sygeneic rats. A rapid stereotaxic method greatly improved the consistency of tumor placement. The optimal site was found to be the caudate nucleus. The production of a spheroid intracerebral growth was further facilitated by the use of 1% agar in the cell suspension medium and by an injection volume of 10 mu1 containing at least 10(4) cells. Further improvements involved injection technique and flushing of the operative field. These modifications have resulted in a 99% to 100% yield of intracerebral growth, with a marked reduction in the number and size of extracranial extensions and with distant metastasis rates of 0% to 5%. These results have continually improved with further experience. The method is satisfactory for radiation and chemotherapeutic trials in which survival time as an index of tumor size may be used an an end point.

Animals↗

The effect of dimethyl sulfoxide on gray matter injury in experimental spinal cord trauma.

The possible effect of dimethyl sulfoxide upon the development of lesions in the gray matter after experimental spinal cord trauma has been investigated with the use of cytochrome oxidase assay and quantitative histologic measurement of total liquefaction necrosis. Observations were made in 17 unconditioned dogs receiving an impact trauma of 400 gm cm force. Experimental animals were given 2.5 gm/kg of dimethyl sulfoxide in 40% solution intravenously one hour prior to trauma, and control animals received a similar volume of saline. No reduction could be found in the degree of loss of cytochrome oxidase at one hour after trauma, nor in the extent of acute necrosis. A slight but non-significant increase in the amount of hemorrhage was noted in gray matter at the trauma site following treatment with dimethyl sulfoxide. The agent resulted in an increase in cytochrome oxidase activities in nontraumatized control gray matter.

Animals↗